Camber Launches Magnesium Sulfate Injection

Camber, a leader in generic drug approvals and launches, is proud to add Magnesium Sulfate Injection, USP [mag-NEE-see-um-SUL-fate] to its growing portfolio.
Magnesium Sulfate Injection, USP is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.
Magnesium Sulfate Injection, USP is available in:
Strength | Size |
1g / 2mL (500mg per mL) * | 25 x 2 mL Single-Dose Vials |
5g / 10mL (500mg per mL) | 25 x 10 mL Single-Dose Vials |
10g / 20mL (500mg per mL) | 25 x 20 mL Single-Dose Vials |
25g / 50mL (500mg per mL) * | 25 x 50 mL Single-Dose Vials |
*Camber Pharmaceuticals has 180-day exclusivity on 1g / 2mL (500mg per mL) and 25g / 50mL (500mg per mL).
To learn more about this product, visit: www.camberpharma.com/magnesium-sulfate
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection